The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors
Classification Results
AI Classification
PositiveFine-tuned Classification
PositiveAI Classification
PositiveFine-tuned Classification
PositiveThe endocannabinoid system as a target for the treatment of neuronal damage